Skip to main content

Ex-NIEHS director speaks out

National Institute of Environmental Health Sciences (NIEHS) director David Schwartz, who officially linkurl:resigned;https://www.the-scientist.com/blog/display/54296/ from the agency last Friday, told __The Scientist__ that NIEHS "could do better" and will "be more successful" under new leadership. Schwartz also said that the environmental health community misunderstood his goals as director of NIEHS. "There was a belief that I was creating a clinical institute," he said, "when I had no intentio

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
National Institute of Environmental Health Sciences (NIEHS) director David Schwartz, who officially linkurl:resigned;https://www.the-scientist.com/blog/display/54296/ from the agency last Friday, told __The Scientist__ that NIEHS "could do better" and will "be more successful" under new leadership. Schwartz also said that the environmental health community misunderstood his goals as director of NIEHS. "There was a belief that I was creating a clinical institute," he said, "when I had no intention of creating a clinical institute." Schwartz was criticized by legislators, and scientists both inside and outside NIEHS for steering the agency away from its traditional focus on research into the prevention of environmentally mediated disease and towards more clinical aspects of these diseases. "We wanted to attract more physician/scientists to the institute," Schwartz said. "For some reason, that was misinterpreted as funding only physician/scientists." "I was also promoting the idea that environmental science had a unique opportunity to use exposures to uniquely understand the etiology, mechanisms, and factors that are associated with the progression of disease," Schwartz continued. Schwartz also defended his decision in 2005 to suggest privatizing NIEHS's flagship journal, __Environmental Health Perspectives (EHP)__, a proposition that raised the ire of the environmental health community. He said that exploring privatization was just part of his institute-wide search for ways to trim the institute's budget. "__Environmental Health Perspectives__ was one of our expenditures that I thought was important to look at carefully," Schwartz said. Schwartz eventually wrote against privatizing __EHP__ in an linkurl:editorial;https://www.ehponline.org/docs/2006/114-8/director.html that was published in the journal's August 2006 issue. In response to linkurl:allegations;https://www.the-scientist.com/news/display/53502/ of misconduct - for example, trading on his status as NIEHS director by testifying as an expert witness in asbestos court cases and diverting resources away from NIEHS researchers to fund his own lab - Schwartz said that any rule breaking he did was out of ignorance. "I thought I was acting within the bounds of what I had received permission to do," he said. "If there were things I did that exceeded those bounds, it was because I didn't understand that or people around me didn't understand that." Schwartz also said that he was stung when almost 100 NIEHS researchers held a linkurl:secret ballot;https://www.the-scientist.com/news/display/53502/ to express their opposition to his leadership and their view that Schwartz had damaged morale at the institute. "Obviously, I was personally disappointed," he said. When asked if he had any regrets concerning his turbulent tenure as NIEHS director, Schwartz said: "Of course I would have done things differently, but hindsight is always 20/20." "I believed, and I still believe, I had the best intentions for the institute in terms of the efforts I put into my position and the leadership I provided." CORRECTION (Feb. 12, 2007): When originally posted, this article contained a misspelling in one of David Schwartz's quotes. __The Scientist__ regrets the error.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays